Dopamine Phenolic (dopamine hydrochloride) NDC 44911-0195

NDC codes

FDA NDC Directory

Product NDC (as listed)44911-0195Labeler and product segments. Claims need a package NDC.

Product NDC at billing width44911-0195Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
44911-0195-1	44911019501	30 mL in 1 BOTTLE, DROPPER (44911-0195-1)Marketed from Jul 14, 2015

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dopamine Phenolic
Generic name (nonproprietary): dopamine hydrochloride
Active ingredients: Dopamine hydrochloride — 6 [hp_X]/mL
Dosage form: Liquid
Route: Oral
Labeler: Energique, Inc.
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Jul 14, 2015
Listing expires: Dec 31, 2026
Other FDA classes: Catecholamines (Chemical structure)
Identifiers: Product ID 44911-0195_c1bbf869-3167-4178-a099-eafe2d629412SPL ID c1bbf869-3167-4178-a099-eafe2d629412SPL set ID d10ca5bc-2612-4589-a49c-1b9935fa0bf3UNII 7L3E358N9LUPC 0363113700992
Pharmacologic class: Catecholamine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N444911019501 followed by a unit qualifier and the quantity

Package 44911-0195-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 24, 2024.

Indications (excerpt from the label)

INDICATIONS: May temporarily relieve symptoms associated with reactions to dopamine.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)